[1]
T. Molnár, K. Farkas, T. Nyári, Z. Szepes, F. Nagy, and T. Wittmann, “Frequency and Predictors of loss of Response to Infliximab or Adalimumab in Crohn’s Disease after One-Year Treatment Period – A Single Center Experience”, JGLD, vol. 21, no. 3, pp. 265–269, Sep. 2012.